Berkeley Communications
HTA in the news
Ozempic and Weight Loss Drugs
Drugwatch
Using insights from our podcast series, Beyond the Scale: The Ozempic Effect, Drugwatch examines the complexities of insurance coverage, the role of health care providers and the risks of off-label use.
Read moreHealth Expert Behind The ACA Reveals The Business Case For Personalized Healthcare At Work
Allwork.Space
Former U.S. Representative Robert E. Andrews reveals how personalized healthcare and AI can slash costs, boost loyalty, and transform your company’s culture — one smart benefit at a time.
Read moreRethinking the ROI of Healthcare Coverage with Robert E. Andrews
Future of Work Podcast
Robert E. Andrews, CEO of the Health Transformation Alliance and architect of the ACA, shares how distributed workforces are reshaping employer healthcare.
Listen nowWill Trump’s new EO really lower prescription drug prices?
Human Resource Executive
It’s a fact that Americans—and, by extension, U.S. employers—pay the highest prescription drug prices in the world.
Read moreRobert Andrews Of The Health Transformation Alliance On 5 Things We Must Do To Improve the US Healthcare System
Authority Magazine
Every Mom and Every Baby should get top-shelf care from conception to delivery.
Read moreEmployer, Insurer Groups Urge Reset on Mental Health Parity Rule
Bloomberg Law
Industry groups say they hope the Trump administration will revisit a number of mental health parity requirements after federal agencies paused enforcement on a key rule, signaling a regulatory revamp.
Read moreTrump signs EO to lower drug prices, industry response is mixed
Healthcare Brew
Pharma companies love the news, but analysts express concern over how it may impact payers and hospitals.
Read moreWhy Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
The New York Times
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
Read more